I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hantel, Andrew
45
results:
Search for persons
X
Format
Online (45)
Mediatypes
Articles (Online) (20)
OpenAccess-fulltext (25)
Sorted by: Relevance
Sorted by: Year
?
1
Racial and ethnic associations with comprehensive cancer ce..:
Hantel, Andrew
;
Brunner, Andrew M
;
Plascak, Jesse J
...
JNCI: Journal of the National Cancer Institute. , 2024
Link:
https://doi.org/10.1093/..
?
2
Association of social deprivation with survival in younger ..:
Rebechi, Melanie
;
Kohlschmidt, Jessica
;
Mrózek, Krzysztof
...
Blood Advances. 7 (2023) 15 - p. 4019-4023 , 2023
Link:
https://doi.org/10.1182/..
?
3
Sociodemographic associations with uptake of novel therapie..:
Hantel, Andrew
;
Cernik, Colin
;
Uno, Hajime
...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
Use, variability, and justification of eligibility criteria..:
Hantel, Andrew
;
Luskin, Marlise R.
;
Khan, Irum
...
Haematologica. , 2023
Link:
https://doi.org/10.3324/..
?
5
Author Correction: Fit older adults with advanced myelodysp..:
Abel, Gregory A.
;
Kim, Haesook T.
;
Hantel, Andrew
...
Leukemia. 35 (2021) 4 - p. 1223-1223 , 2021
Link:
https://doi.org/10.1038/..
?
6
Peri‐transfusion quality‐of‐life assessment for patients wi..:
Abel, Gregory A.
;
Klepin, Heidi D.
;
Magnavita, Emily S.
...
Transfusion. 61 (2021) 10 - p. 2830-2836 , 2021
Link:
https://doi.org/10.1111/..
?
7
Racial and ethnic enrollment disparities and demographic re..:
Hantel, Andrew
;
Luskin, Marlise R.
;
Garcia, Jacqueline S.
...
Blood Advances. 5 (2021) 21 - p. 4352-4360 , 2021
Link:
https://doi.org/10.1182/..
?
8
Gait speed, survival, and recommended treatment intensity i..:
Hantel, Andrew
;
DuMontier, Clark
;
Odejide, Oreofe O.
...
Cancer. 127 (2020) 6 - p. 875-883 , 2020
Link:
https://doi.org/10.1002/..
?
9
Fit older adults with advanced myelodysplastic syndromes: w..:
Abel, Gregory A.
;
Kim, Haesook T.
;
Hantel, Andrew
...
Leukemia. 35 (2020) 4 - p. 1166-1175 , 2020
Link:
https://doi.org/10.1038/..
?
10
Practical allocation system for the distribution of special..:
Hantel, Andrew
;
Abel, Gregory A
;
Siegler, Mark
Journal of Medical Ethics. 45 (2019) 8 - p. 532-537 , 2019
Link:
https://www.jstor.org/st..
?
11
Measurable residual disease monitoring for patients with ac..:
Balagopal, Vidya
;
Hantel, Andrew
;
Kadri, Sabah
...
PLOS ONE. 14 (2019) 10 - p. e0224097 , 2019
Link:
https://doi.org/10.1371/..
?
12
Molecular Minimal Residual Disease Testing in Acute Myeloid..:
Hantel, Andrew
;
Stock, Wendy
;
Kosuri, Satyajit
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) 10 - p. 636-647 , 2018
Link:
https://doi.org/10.1016/..
?
13
Safety and Efficacy of the BCL Inhibitors Venetoclax and Na..:
Hantel, Andrew
;
Wynne, Joseph
;
Lacayo, Norman
...
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) - p. S184-S185 , 2018
Link:
https://doi.org/10.1016/..
?
14
Severe hemophagocytic lymphohistiocytosis in a melanoma pat..:
Hantel, Andrew
;
Gabster, Brooke
;
Cheng, Jason X.
..
Journal for ImmunoTherapy of Cancer. 6 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1186/..
?
15
Imatinib is still recommended for frontline therapy for CML:
Hantel, Andrew
;
Larson, Richard A.
Blood Advances. 2 (2018) 24 - p. 3648-3652 , 2018
Link:
https://doi.org/10.1182/..
1-15